Injective (INJ) is eyeing a potential rise to $5.50 as speculation around an ETF and institutional partnerships fuel bullish sentiment. Currently trading near $4.15, INJ has maintained critical support above $4.10 despite recent volatility. Analysts suggest that if this support holds, the price could consolidate and aim for higher resistance levels. Recent developments have bolstered confidence in Injective's ecosystem. The launch of USDC and Circle's Cross-Chain Transfer Protocol on the network has expanded liquidity and cross-chain functionality. Additionally, discussions at Consensus 2026 highlighted Injective's potential for regulated futures and ETFs, increasing institutional interest. An SEC S-4 filing confirmed Injective as a blockchain partner for Securitize, enhancing its role in tokenized finance. The network also completed a token buyback and recorded significant developer activity, ranking among the top blockchain networks for revenue generation.